Both pooled PDE5-Is and individual PDE5-Is (sildenafil and vardenafil) outperformed the
placebo in the improvement of all IIEF domain scores. A recent meta-analysis recommended …

Introduction Erectile dysfunction (ED) is a very common multidimensional disorder affecting
men worldwide. Physical illness, reaction to life stresses, or an unhappy couple relationship …

Introduction Erectile dysfunction (ED) is reported in a high percentage of patients with
central neurological disorders (CND). Aim An up-to-date review on oral phosphodiesterase …

Sexual dysfunction is an important part of symptomatology in depression and anxiety and
can be a serious side effect of treatment of depression or psychosis. PDE-5 inhibitor …

Abstract Phosphodiesterase type-5 (PDE-5) inhibitors are a new class of vasoactive drugs
that have been developed for treatment of erectile dysfunction (ED). The mechanism of …

Background: Erectile dysfunction (ED) is a common male sexual disorder. The relative
benefits and harms of pharmacologic therapies for ED, as well as the value of hormonal …

Background: Erectile dysfunction (ED) is increasingly being recognized as a sentinel marker
of future subsequent cardiovascular disease (CVD). Predicted increases in the prevalence …

Introduction In male sexual dysfunction (MSD), the presence of sexual comorbidities is
relatively frequent. However, what is still a matter of controversy is what the first‐line therapy …

Abstract Purpose of Review Erectile dysfunction (ED) is an increasingly common concern
that has been a topic of interest to men (and their partners) since time immemorial. In the …

Introduction Several methods have been so far proposed to compare the effectiveness of the
three available phosphodiesterase type 5 inhibitors (PDE5Is). Methods Two urologists (EC …